Personalized Genetic Risk Counseling to Motivate Diabetes Prevention: A randomized trial

• Published in: Diabetes care Vol. 36; no. 1; pp. 13 - 19
• Main Authors: GRANT, Richard W, O'BRIEN, Kelsey E, FLOREZ, Jose C, MEIGS, James B, WAXLER, Jessica L, VASSY, Jason L, DELAHANTY, Linda M, BISSETT, Laurie G, GREEN, Robert C, STEMBER, Katherine G, GUIDUCCI, Candace, PARK, Elyse R
• Format: Journal Article
• Language: English
• Published: Alexandria, VA American Diabetes Association 01.01.2013
• Subjects: Aged; Behavior; Biological and medical sciences; Chromosomes; Clinical trials; Diabetes; Diabetes Mellitus, Type 2 - genetics; Diabetes Mellitus, Type 2 - prevention & control; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Female; Genetic aspects; Genetic Counseling; Genetic screening; Genetic Testing; Genetics; Health risk assessment; Humans; Male; Medical genetics; Medical sciences; Metabolic diseases; Middle Aged; Miscellaneous; Motivation; Original Research; Overweight; Prevention; Public health. Hygiene; Public health. Hygiene-occupational medicine; Type 2 diabetes; Massachusetts; Endocrinopathy; Human; Prevention; Randomization; Genetic counseling; Nutrition; Diabetes mellitus; Risk factor; Clinical trial; Metabolic diseases; Risk; Endocrinology
• ISSN: 0149-5992; 1935-5548
• DOI: 10.2337/dc12-0884

To examine whether diabetes genetic risk testing and counseling can improve diabetes prevention behaviors. We conducted a randomized trial of diabetes genetic risk counseling among overweight patients at increased phenotypic risk for type 2 diabetes. Participants were randomly allocated to genetic testing versus no testing. Genetic risk was calculated by summing 36 single nucleotide polymorphisms associated with type 2 diabetes. Participants in the top and bottom score quartiles received individual genetic counseling before being enrolled with untested control participants in a 12-week, validated, diabetes prevention program. Middle-risk quartile participants were not studied further. We examined the effect of this genetic counseling intervention on patient self-reported attitudes, program attendance, and weight loss, separately comparing higher-risk and lower-risk result recipients with control participants. The 108 participants enrolled in the diabetes prevention program included 42 participants at higher diabetes genetic risk, 32 at lower diabetes genetic risk, and 34 untested control subjects. Mean age was 57.9 ± 10.6 years, 61% were men, and average BMI was 34.8 kg/m(2), with no differences among randomization groups. Participants attended 6.8 ± 4.3 group sessions and lost 8.5 ± 10.1 pounds, with 33 of 108 (30.6%) losing ≥5% body weight. There were few statistically significant differences in self-reported motivation, program attendance, or mean weight loss when higher-risk recipients and lower-risk recipients were compared with control subjects (P > 0.05 for all but one comparison). Diabetes genetic risk counseling with currently available variants does not significantly alter self-reported motivation or prevention program adherence for overweight individuals at risk for diabetes.